213 related articles for article (PubMed ID: 23477784)
21. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
22. Drug-conjugated monoclonal antibodies for the treatment of cancer.
Lambert JM
Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody-based therapies in cancer: advances and challenges.
Sapra P; Shor B
Pharmacol Ther; 2013 Jun; 138(3):452-69. PubMed ID: 23507041
[TBL] [Abstract][Full Text] [Related]
24. Antibody-drug conjugates in tumor therapy.
Sammet B; Steinkühler C; Sewald N
Pharm Pat Anal; 2012 Mar; 1(1):65-73. PubMed ID: 24236714
[TBL] [Abstract][Full Text] [Related]
25. Rationale for the clinical use of immunotoxins: monoclonal antibodies conjugated to ribosome-inactivating proteins.
Preijers FW
Leuk Lymphoma; 1993 Mar; 9(4-5):293-304. PubMed ID: 8348066
[TBL] [Abstract][Full Text] [Related]
26. [Immunoconjugates, drug-armed antibodies to fight against cancer].
Haeuw JF; Caussanel V; Beck A
Med Sci (Paris); 2009 Dec; 25(12):1046-52. PubMed ID: 20035677
[TBL] [Abstract][Full Text] [Related]
27. Risks and untoward toxicities of antibody-based immunoconjugates.
Litvak-Greenfeld D; Benhar I
Adv Drug Deliv Rev; 2012 Dec; 64(15):1782-99. PubMed ID: 22659123
[TBL] [Abstract][Full Text] [Related]
28. Immunotoxins.
Kreitman RJ
Expert Opin Pharmacother; 2000 Sep; 1(6):1117-29. PubMed ID: 11249483
[TBL] [Abstract][Full Text] [Related]
29. Recent Patents on Heat Shock Proteins Targeting Antibodies.
Fernandes JC; Alves P
Recent Pat Anticancer Drug Discov; 2017; 12(1):48-54. PubMed ID: 27881057
[TBL] [Abstract][Full Text] [Related]
30. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
Arosio D; Manzoni L; Corno C; Perego P
Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
[TBL] [Abstract][Full Text] [Related]
31. Drug targeting with monoclonal antibodies. A review.
Blakey DC
Acta Oncol; 1992; 31(1):91-7. PubMed ID: 1637417
[TBL] [Abstract][Full Text] [Related]
32. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
Lorberboum-Galski H
Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
[TBL] [Abstract][Full Text] [Related]
33. [Application of monoclonal antibody for drug delivery system--missile therapy for cancer].
Yamaguchi T; Takahashi T; Kitamura K; Otsuji E; Sakakura C; Okamoto K; Tsuruta H; Ichikawa D; Matsumura H; Yamamoto K; Nishida T; Kimura A
Nihon Rinsho; 1998 Mar; 56(3):638-43. PubMed ID: 9549349
[TBL] [Abstract][Full Text] [Related]
34. New antibody conjugates in cancer therapy.
Govindan SV; Goldenberg DM
ScientificWorldJournal; 2010 Oct; 10():2070-89. PubMed ID: 20953556
[TBL] [Abstract][Full Text] [Related]
35. Antibody conjugates and therapeutic strategies.
McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
[TBL] [Abstract][Full Text] [Related]
36. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.
Ma Z; He H; Sun F; Xu Y; Huang X; Ma Y; Zhao H; Wang Y; Wang M; Zhang J
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1929-1940. PubMed ID: 28536738
[TBL] [Abstract][Full Text] [Related]
37. [Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
Yachi A; Imai K; Hirata H; Hishikawa N
Nihon Rinsho; 1989 Jun; 47(6):1391-5. PubMed ID: 2475654
[No Abstract] [Full Text] [Related]
38. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
39. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
Pimm MV
Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic targets and recent advances in protein immunotoxins.
Madhumathi J ; Verma RS
Curr Opin Microbiol; 2012 Jun; 15(3):300-9. PubMed ID: 22647353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
